EN

Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Campus life

Discover the campuses

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Join our programs

Shaker Gene.iO ATIGE

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Directories Our network

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Come to our events

Innovate with us

Discover >

Quick access

Company

PHARMING

5, rue Henri Desbruères
Bâtiment 8 – Porte 814
91030 EVRY Cedex – FRANCE
Phone : +33 1 69 90 61 23
Email: p.ripoll@pharming.com

Bruno GIANNETTI: President France
Web Site >
Pharming - Genopole's company - Logo 2021 Pharming - Genopole's company - Logo 2021

#Industrial Biotech #Therapeutics

  • Recombinant protein
  • Protein production
  • Transgenic rabbit

Field of Activity

Pharming specializes in the production of recombinant proteins in transgenic rabbit milk.

BACKGROUND
Pharming Group N.V. is committed to the development of innovative products for the treatment of unmet medical needs.

We focus on the development and production of human therapeutic proteins to provide life-changing solutions to patients.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY

  • Vision: Pharming’s vision is to be a leader in developing bio-pharmaceuticals, improving health and meeting patients’needs.
  • Mission: Pharming’s mission is to develop innovative products for significant medical needs based on our own and our partners’ proprietary research and technologies.
    We operate to high ethical, environmental and animal welfare standards.
  • Strategy: Our strategy is to orchestrate the complete development of innovative therapeutics for significant medical needs.
    We thereby concentrate on our core competencies and form strategic partnerships in other field.
Share
Genopole’s Companies

#Industrial Biotech

In the same field

The Very Food Co. - Logo - Genopole Company

The VERY Food Co

Activity of research, sale, production, distribution and marketing of all unregulated food and agri-food products.

Discover
STH Biotech - Genopole's company

STH Biotech

STH BIOTECH is developing an innovative cannabis-based process for the reliable and sustainable production of active compounds for the well-being and healthcare sectors.

Discover
Synovance - entreprise généopolitaine

Synovance

Synovance has developed a revolutionary synthetic genomics platform for the conception of robust industrial bioproduction strains.

Discover
Altar - entreprise génopolitaine - intégre le groupe Ginko Bioworks

Altar

Ginkgo Bioworks is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Discover
Yposkesi - Genopole's Company

Yposkesi, an SK pharmteco Company

YposKesi is the first French company to develop and manufacture gene and cell therapy products for rare diseases.

Discover
Watchfrog Laboratory - Genopole's company

WatchFrog

WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.

Discover
Global Bioenergies - entreprise génopolitaine - logo 2022

Global Bioenergies

Global Bioenergies is developing a process to convert renewable resources into hydrocarbons through fermentation.

Discover
ABOLIS - entreprise génopolitaine

Abolis Biotechnologies

Abolis develops custom-order microorganisms able to produce molecules of interest via fermentation for the health, nutrition, chemistry and cosmetics sectors.

Discover
View all >
With the support from
Région île de France
Ministère de l'Enseignement supérieur et de la recherche AFM-Téléthon
Communauté d'agglomération Grand Paris Sud
Département de l'Essonne - Terre D'avenirs Ville d'Evry-Courcouronnes 2023 CEA Inserm Centre hospitalier Sud Francilien Université d'Evry - Paris Saclay Université PAris-Saclay SEM Genopole

Keep up to date with Genopole’s latest events and news